Marzena Watek - Publications

Identification of novel genetic loci for risk of multiple myeloma by functional annotation.

Journal: Leukemia

Published: March 08, 2023

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.

Journal: International journal of molecular sciences

Published: March 04, 2023

Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: January 13, 2022

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.

Journal: International journal of cancer

Published: December 07, 2021

Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG).

Journal: Cancers

Published: June 28, 2021

Genetically determined telomere length and multiple myeloma risk and outcome.

Journal: Blood cancer journal

Published: September 07, 2020

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.

Journal: International journal of cancer

Published: May 18, 2020

Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis.

Journal: Digestive diseases and sciences

Published: April 25, 2020

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.

Journal: International journal of cancer

Published: April 15, 2020

A polygenic risk score for multiple myeloma risk prediction.

Journal: European journal of human genetics : EJHG

Published: March 25, 2020

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: December 20, 2019

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.

Journal: Leukemia & lymphoma

Published: November 21, 2019